Dear people,
If u wanna know more about the epidemiology of malignant melanoma, please do visit the links below. They are superb.
Reference
http://emedicine.medscape.com/article/1100753-overview
Difference between benign and malignant tumours
The two important differences between benign and malignant tumours are invasion and spread.
• As they grow benign tumours simply push the surrounding normal tissues and organs out of their way. Sometimes pressure from a benign tumour may damage surrounding structures but the benign tumour never actually invades into those structures. By contrast malignant tumours eat into and destroy the normal tissue around them as they increase in size. This means that in some parts of the body benign tumours can grow quite large without causing any problems whereas a malignant tumour damages the tissue around it from the time it first begins to grow.
• Benign tumours do not spread. They may grow to a large size but they do not go to other parts of the body. Malignant tumours have the ability to spread by sending off seedlings of tumour which can pass through the blood or lymphatic system to other parts of the body. These seedlings then settle in other organs and form what are called secondary tumours or metastases.Whilst all malignant tumours have the ability to spread, different tumours vary in the speed with which they do so.
• The difference between benign and malignant tumours has nothing to do with frequency - in some organs of the body benign tumours are much more common than cancers, nor does it have anything to do with size, some benign tumours can be very large whilst many cancers are quite small.
•The different types of benign and malignant tumours behave in different ways but the fundamental rule that benign tumours never invade or spread always applies
Confirmatory test
• Doctors can tell if a tumour is benign or malignant by examining a small sample of cells under a microscope. This is called a biopsy.
• First, Imaging
• Imaging can be used to find out where a cancer is located in the body, if it has spread, and how much is present. E.g. ultrasound, MRI, or PET/CT CT scans
• Then, Biopsy (removal of a small piece of tissue for lab exmination) / Tissue sampling
E.g. Fine-needle aspiration, Core needle biopsy, Vacuum-assisted biopsy, Image-guided biopsy
How the Test is Performed
There are several different types of biopsies.
A needle (percutaneous) biopsy removes tissue using a hollow tube called a syringe. A needle is passed through the syringe into the area being examined. The surgeon uses the needle to remove the tissue sample. Needle biopsies are often done using x-rays (usually CT scan), which guide the surgeon to the appropriate area.
An open biopsy is a surgery that uses general anesthesia. This means you are asleep and pain-free during the procedure. The procedure is done in a hospital operating room. A surgeon makes a cut into the affected area, and the tissue is removed.
Closed biopsy uses a much smaller surgical cut than open biopsy. A small cut is made so that a camera-like instrument can be inserted. This instrument helps guide the surgeon to the appropriate place to take the sample.
How to know whether the tumour is malignant or benign
The overall size and shape of cancer cells are often abnormal. They may be either smaller or larger than normal cells.
The size and shape of the nucleus of a cancer cell is often abnormal. Cancer cells typically have a nucleus that is larger than that of a normal cell. And, like the overall cell size and shape, the size and shape of the cell nucleus is generally similar among normal cells of each tissue but can vary greatly among cancer cells. Another feature of the nucleus of a cancer cell is that it appears darker when seen under a microscope after being stained with certain dyes. The nucleus from a cancer cell is larger and has a darker shade because it often contains too much DNA.
Cancer cells do not relate to each other normally. Sometimes the cancer cells form abnormal or distorted glands. Sometimes they form cell clumps that do not look like glands at all. Another feature that shows abnormal interactions by cancer cells is that cancer cells invade other tissues. Normal cells stay where they belong within a tissue.
Risks
• Bleeding
• Infection
LINKS
http://www.nlm.nih.gov/medlineplus/cancer.html
http://www.insidecancer.org/
http://www.cancerbackup.org.uk/Aboutcancer/Whatiscancer/Whatiscancer
http://www.nlm.nih.gov/medlineplus/benigntumors.html
www.nlm.nih.gov/medlineplus/ency/article/003416.htm
http://www.mayoclinic.com/health/biopsy/ca00083
http://www.cancer.org/docroot/ped/content/ped_2_3x_testing_biopsy_and_cytology_specimens_for_cancer.asp?sitearea=ped
Summary-Nobody Is Immune(PCL WEEK 8)
1) Immune system
(A network of cells, tissues, and organs that work together to defend the body against attacks by pathogens)
First line of defence (Skin, Lysozyme, Clotting of blood, Mucus and cilia)
Second line of defence (innate immune system (non-specific) and adaptive immune system (specific); Involves leukocytes)
Immunity (Active and passive; Natural and Artificial)
Herd Immunity
If immunity rates in a society is high, then protection will aslo be conferred to those who are unvaccinated.
2) Pertussis
i) Incidence & Prevalence
According to age (US):
2001-2003
<1>
1-4 years – 12 %
5-9 years - 9%
10-19 years – 33%
20 years - 23%
In Malaysia
Decrease after introduction of vaccine
0.02 per 100 000 population. (2006)
ii) Causes & Predisposing factors
Caused by a bacteria called Bordatella pertussis
Predisposing factors: Direct/Indirect Contact, Airbone droplets, Not being immunized.
iii) Pathophysiology
-Typically attacks children
-3 stages : Catarrhal àParoxysmalàConvalescent
Pathophysiology :
-Bordetella pertussis attaches to and multiplies on the respiratory epithelium. This damages ciliated respiratory epithelium.
-The damage starts in the nasopharynx and ends primarily in the bronchi and bronchioles
-Cilia is attacked by bacteria and with the accumulation of debris in the respiratory tract, mucus is produced
-As the body can’t get rid of the mucus in the airways, coughing and inhalation with a whistling or whooping sound entails.
-This causes difficulty in breathing
Whistling/whooping sound :
-Narrowing of the lower respiratory tract and is caused by mucus
-Air moves through the narrowed space, it sounds like whistling or whoosing.
-Often comes from the small breathing tubes (bronchial tubes) deep in the chest
iv) Complications & Symptoms
The first stage- runny nose, sneezing, low-grade fever, mild, occasional cough, similar to the common cold.
The second stage-Bursts (paroxysms) , breathing in accompanied by a characteristic high-pitched "whoop" sound, individual may become cyanotic (turn blue) from lack of oxygen, Children and young infants appear especially ill and distressed, Vomiting and exhaustion
The third stage -The cough becomes less paroxysmal and usually disappears
Complications -secondary bacterial pneumonia,seizures,encephalopathy,reactive airway disease,dehydration,malnutrition.
v) Differential Diagnosis
1. Asthma
Pertussis is also associated with vomiting and sputum. To confirm whether it is asthma or pertussis a definitive culture diagnosis or blood-work is done.
2. Pneumonia
Pertussis is not asscociated with joint pains and shaking chills. Hence, pneumonia is ruled out.
3. Tuberculosis
Lupus vulgaris and chroiditis is not associated with the symptoms of Pertussis. Hence Tuberculosis is ruled out.
4. Febrile Seizures
Pertussis is not associated with otitis media. Hence, Febrile seizure is ruled out.
vi) Management & Treatment
Medical Care
· The goals of therapy include limiting the number of paroxysms, observing the severity of cough, providing assistance when necessary, and maximizing nutrition, rest, and recovery.
· Hospitalization-Monitor heart rate, respiratory rate, and oxygen saturation of hospitalized patients continuously, especially in relation to coughing paroxysms. Coughing, feeding, vomiting, and weight changes should be recorded.
· Pay attention to the young infant's hydration and nutritional status.
· Patients who are severely ill may require treatment in an ICU.
Medication - Antimicrobial agents, Pertussis-specific immune globulin ,Antibiotics(oral (PO) erythromycin, macrolide antibiotics(erythromycin, clarithromycin, and azithromycin, trimethoprim-sulfamethoxazole).
vii) Prevention – Maintain hygiene, Avoid contact with infected people, Isolation, Vaccination and Booster vaccination, Education.
3)Safety of vaccination & Immunisation schedule
1) Greatest success story in public health: reduction of infectious diseases resulting from the use of vaccines.
eg. Reduced preventable infectious diseases (measles, pertussis, diphtheria)
2) Prior to approval by FDA, vaccines are tested extensively by scientists to ensure they are effective and safe. But no vaccine is 100% safe or effective. (depends on individual immune systems)
- Mice, guinea pigs, rabbits, monkeys
- FDA approves clinical studies
- Human subjects (voluntary), computers used to predict how the vaccine will interact with the immune system
- 3 phases: small (20-100 volunteers) a few months,
larger (several hundred volunteers) months to years,
larger still (several hundreds to thousands) several years.
3) Agencies involved in vaccine safety regulation:
a) National Vaccine Program Office (NVPO) under National Childhood Vaccine Injury Act (NCVIA)
- Vaccine Adverse Event Reporting System (VAERS) by CDC and FDA in 1990
- National Vaccine Injury Compensation Program (NVICP)
b) Department of Health and Human Services (DHHS)
- Centers for Disease Control and Prevention (CDC),
- Food and Drug Administration (FDA)
- National Institutes of Health (NIH)
- Health Resources and Services Administration (HRSA).
4) Six Common Misconceptions By CDC 29 May 2007
| |
BCG (birth), DtaPHibHep(2,3,5 months), DTwPHib(2,3,5,18 months), HepB(birth,2,3,5 months),IPV(2,3 months), JapEnc(9,10,18 months;5,8,11,14 years), Measles ( 6months), MenACWY (Hajj Pilgrims), MMR(12 months;7 years), OPV (2,3,5,18 months; 7 years), TT(15 years), Typhoid(food handlers), YF (visitors to Yellow fever endemic countries)
4)Role of parents and government on protecting infectious diseases(Covered in Mock-Trial)
Role of Government:
· monitoring, analysing and reporting on vaccine preventable diseases (VPDs) as well as bacterial, bloodborne and sexually transmitted diseases
· providing timely, accurate and relevant surveillance advice to inform policy and response activities relating to VPDs, including pandemic planning
· providing stakeholders with information on the impacts that VPDs and other communicable diseases could pose to Australia, including through cross-jurisdictional and international trend analysis
· managing and contributing to committees on VPD and other communicable disease issues
· engaging data providers and stakeholders to enhance collection and collation of VPD information.
Role of family:(maintain hygiene, immunization, nutrition, healthy lifestyle)
5)Legal & social implications on not getting child immunised(Covered in Mock-Trial)
· Patients autonomy, Children and Young Persons Act 1933, Assessment of vaccination, Herd Immunity